Mark Arnold

Mark Arnold is an experienced professional in the pharmaceutical and biotechnology industries, currently serving as the Corporate Account Director for US Corporate Accounts at Genmab since August 2022. Prior to this role, Mark held the position of Director of Strategic Accounts at The Janssen Pharmaceutical Companies of Johnson & Johnson from October 2020 to August 2022. Mark's extensive background includes roles as Oncology Key Account Manager and Executive Oncology Specialist at Janssen Oncology Inc from May 2007 to October 2020, as well as Senior Financial Analyst at Centocor Ortho Biotech Inc from January 2005 to May 2007. Previously, Mark worked at Armstrong World Industries in various accounting roles from October 1999 to January 2005, and held positions as Corporate Accountant and Cost Accountant at Tyco from 1995 to 1999. Mark holds a Master of Business Administration in Finance from the University of Scranton and a Bachelor's degree in Accounting along with an Associate's degree in Marketing from King's College.